Glenmede Trust’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-36
Closed 1812
2020
Q3
$0 Hold
36
﹤0.01% 2540
2020
Q2
$0 Buy
+36
New +$534 ﹤0.01% 2549
2017
Q3
Sell
-46
Closed -$3K 2790
2017
Q2
$3K Hold
46
﹤0.01% 2400
2017
Q1
$3K Hold
46
﹤0.01% 2400
2016
Q4
$3K Sell
46
-26,330
-100% -$1.71M ﹤0.01% 2309
2016
Q3
$1.75M Sell
26,376
-6,675
-20% -$457K 0.01% 650
2016
Q2
$2.39M Sell
33,051
-30,582
-48% -$2.1M 0.01% 586
2016
Q1
$4.11M Sell
63,633
-248,268
-80% -$16.5M 0.03% 469
2015
Q4
$22.3M Buy
311,901
+303,498
+3,612% +$22.4M 0.15% 220
2015
Q3
$644K Sell
8,403
-1,565
-16% -$126K ﹤0.01% 820
2015
Q2
$738K Buy
9,968
+1,264
+15% +$91K 0.01% 813
2015
Q1
$630K Buy
8,704
+2,518
+41% +$175K ﹤0.01% 878
2014
Q4
$408K Buy
6,186
+2,834
+85% +$173K ﹤0.01% 1040
2014
Q3
$183K Buy
3,352
+1,830
+120% +$104K ﹤0.01% 1202
2014
Q2
$88K Buy
1,522
+61
+4% +$3.59K ﹤0.01% 1455
2014
Q1
$90K Sell
1,461
-426
-23% -$24.8K ﹤0.01% 1459
2013
Q4
$100K Sell
1,887
-232,263
-99% -$12.5M ﹤0.01% 1402
2013
Q3
$10.3M Buy
234,150
+24,394
+12% +$1.19M 0.12% 222
2013
Q2
$9.6M Buy
+209,756
New +$9.39M 0.12% 180

Other funds holding MD

Glenmede Trust's MD Position: Q4 2020 in Review

Glenmede Trust sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 36 shares.

Glenmede Trust first reported a position in MD in Q2 2013 and held it in 19 quarters. The position peaked at $22.3M in Q4 2015. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

  • Glenmede Trust reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
  • Glenmede Trust sold 36 Pediatrix Medical shares in Q4 2020.
  • Glenmede Trust first reported a position in Pediatrix Medical in Q2 2013 and held it in 19 quarters.
  • Glenmede Trust's Pediatrix Medical position peaked at $22.3M in Q4 2015.
  • 201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.